source
- STAT+: White House offers its science blueprint: More AI, less life sciencesThe Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of research dollars from universities to industry.STAT · 6d ago↗ source
- Gene editor Scribe starts second-half IPO spree with $129M listingA nine-year-old biotech co-founded by CRISPR pioneer Jennifer Doudna is kicking off a run of biotech IPOs set for this year's second half. Scribe Therapeutics priced its $128.7 millionEndpoints · 6d ago↗ source
- Scribe secures $129M in a rare gene editing IPOThe startup is the first gene editing company to price an IPO in more than two years, though it banked far less than most other biotechs that have gone public in 2026.BioPharma Dive